Drug class
Levodopa prodrug; methyl ester of L-DOPA
Mechanism of action
Melevodopa is the methyl ester of levodopa. Following hydrolysis to levodopa, it enters the brain via amino-acid transport and is decarboxylated by aromatic L-amino-acid decarboxylase to dopamine, replenishing deficient striatal dopaminergic signalling.
General use cases
- Investigated and used in some countries as a rapidly absorbed levodopa form for treatment of Parkinson’s disease, generally in combination with a peripheral dopa-decarboxylase inhibitor. Product availability and authorisation are jurisdiction-specific.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
